Judy D. Olian

Director

Judy D. Olian (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $107K of UTHR (200 sh × $535.44, as filed), executed Mar 16.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$417K

shares × price, as filed

Last traded

Mar 23

Filed Mar 24

Median ADV $265.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

UTHR

United Therapeutics Corporation UTHR · 0 buys · 6 sells 6 filings

Recent filings

UTHRSALE United Therapeutics Corporation View filing → $106K
200 sh × $530.00
Exec Mar 23
Filed Mar 24 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $107K
200 sh × $535.44
Exec Mar 16
Filed Mar 16 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $102K
200 sh × $510.00
Exec Mar 6
Filed Mar 9 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $102K
200 sh × $509.55
Exec Feb 27
Filed Mar 2 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $748K
1,800 sh × $415.43
Exec Sep 19 2025
Filed Sep 19 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $722K
1,750 sh × $412.48
Exec Nov 11 2024
Filed Nov 12 2024 · 5:30 PM ET